Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expression

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Feng, Dan ^a   Ohlsson, Lena ^a   Duan, Rui Dong ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BILE SALT; CARBON 14; CARRIER PROTEIN; CURCUMIN; EZETIMIBE; GLYCEROL OLEATE; MESSENGER RNA; NIEMANN PICK CL LIKE 1 PROTEIN; UNCLASSIFIED DRUG; CHOLESTEROL; FLAVONOID; HYPOCHOLESTEROLEMIC AGENT; MEMBRANE PROTEIN; NPC1L1 PROTEIN, HUMAN; PHENOL DERIVATIVE; POLYPHENOLS;

ARTICLE; CELL CULTURE; CELL STRAIN CACO 2; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DOWN REGULATION; MICELLE; POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CYTOLOGY; DRUG EFFECT; GENETICS; HUMAN; INTESTINE; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

CURCUMA LONGA;

ANTICHOLESTEREMIC AGENTS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CHOLESTEROL; CURCUMIN; DOWN-REGULATION; FLAVONOIDS; HUMANS; INTESTINES; MEMBRANE PROTEINS; PHENOLS; RNA, MESSENGER;

EID: 77950955510     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-40     Document Type: Article

References (30)

1. Dietary cholesterol absorption; more than just bile. K Lu MH Lee SB Patel, Trends Endocrinol Metab 2001 12 7 314 320 10.1016/S1043-2760(01)00433-7 11504671
2. Emerging roles of the intestine in control of cholesterol metabolism. JK Kruit AK Groen TJ van Berkel F Kuipers, World J Gastroenterol 2006 12 40 6429 6439 17072974
3. The effect of cholesterol absorption inhibition on low density lipoprotein cholesterol level. H Gylling TA Miettinen, Atherosclerosis 1995 117 2 305 308 10.1016/0021-9150(95)05566-F 8801876
4. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. SW Altmann HR Davis Jr LJ Zhu X Yao LM Hoos G Tetzloff SP Iyer M Maguire A Golovko M Zeng, et al. Science 2004 303 5661 1201 1204 10.1126/science.1093131 14976318
5. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). M Garcia-Calvo J Lisnock HG Bull BE Hawes DA Burnett MP Braun JH Crona HR Davis Jr DC Dean PA Detmers, et al. Proc Natl Acad Sci USA 2005 102 23 8132 8137 10.1073/pnas.0500269102 15928087
6. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. RJ Anto A Mukhopadhyay K Denning BB Aggarwal, Carcinogenesis 2002 23 1 143 150 10.1093/carcin/23.1.143 11756235
7. Curcumin decreases acid sphingomyelinase activity in colon cancer Caco-2 cells. Y Cheng A Kozubek L Ohlsson B Sternby RD Duan, Planta Med 2007 73 8 725 730 10.1055/s-2007-981540 17583825
8. Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). SK Sandur H Ichikawa MK Pandey AB Kunnumakkara B Sung G Sethi BB Aggarwal, Free Radic Biol Med 2007 43 4 568 580 10.1016/j.freeradbiomed.2007.05.009 17640567
9. Effect of curcumin on serum and liver cholesterol levels in the rat. DS Rao NC Sekhara MN Satyanarayana M Srinivasan, J Nutr 1970 100 11 1307 1315 5476433
10. Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. A Asai T Miyazawa, J Nutr 2001 131 11 2932 2935 11694621
11. Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. PS Babu K Srinivasan, Mol Cell Biochem 1997 166 1-2 169 175 10.1023/A:1006819605211 9046034
12. Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. MC Ramirez-Tortosa MD Mesa MC Aguilera JL Quiles L Baro CL Ramirez-Tortosa E Martinez-Victoria A Gil, Atherosclerosis 1999 147 2 371 378 10.1016/S0021- 9150(99)00207-5 10559523
13. The effect of curcumin on lipid level in patients with acute coronary syndrome. I Alwi T Santoso S Suyono B Sutrisna FD Suyatna SB Kresno S Ernie, Acta Med Indones 2008 40 4 201 210 19151449
14. Curcumin effects on blood lipid profile in a 6-month human study. L Baum SK Cheung VC Mok LC Lam VP Leung E Hui CC Ng M Chow PC Ho S Lam, et al. Pharmacol Res 2007 56 6 509 514 10.1016/j.phrs.2007.09.013 17951067
15. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. KB Soni R Kuttan, Indian J Physiol Pharmacol 1992 36 4 273 275 1291482
16. Curcumin induces changes in expression of genes involved in cholesterol homeostasis. D Peschel R Koerting N Nass, J Nutr Biochem 2007 18 2 113 119 10.1016/j.jnutbio.2006.03.007 16713233
17. Curcumin up-regulates LDL receptor expression via the sterol regulatory element pathway in HepG2 cells. X Dou C Fan L Wo J Yan Y Qian X Wo, Planta Med 2008 74 11 1374 1379 10.1055/s-2008-1081316 18704882
18. 3-Hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured fibroblasts from patients with mevalonate kinase deficiency: differential response to lipid supplied by fetal bovine serum in tissue culture medium. KM Gibson G Hoffmann A Schwall RL Broock S Aramaki L Sweetman WL Nyhan IK Brandt RS Wappner W Lehnert, et al. J Lipid Res 1990 31 3 515 521 2160511
19. Regulation of gene expression and synthesis and degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by micellar cholesterolin CaCo-2 cells. FJ Field T Shreves D Fujiwara S Murthy E Albright SN Mathur, J Lipid Res 1991 32 11 1811 1821 1770301
20. Dietary sphingomyelin suppresses intestinal cholesterol absorption by decreasing thermodynamic activity of cholesterol monomers. ER Eckhardt DQ Wang JM Donovan MC Carey, Gastroenterology 2002 122 4 948 956 10.1053/gast.2002.32539 11910347
21. Identification of Human Intestinal Alkaline Sphingomyelinase as a Novel Ecto-enzyme Related to the Nucleotide Phosphodiesterase Family. RD Duan T Bergman N Xu J Wu Y Cheng J Duan S Nelander C Palmberg A Nilsson, J Biol Chem 2003 278 40 38528 38536 10.1074/jbc.M305437200 12885774
22. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. BB Aggarwal B Sung, Trends Pharmacol Sci 2009 30 2 85 94 10.1016/j.tips.2008.11.002 19110321
23. Chemopreventive and therapeutic effects of curcumin. A Duvoix R Blasius S Delhalle M Schnekenburger F Morceau E Henry M Dicato M Diederich, Cancer Lett 2005 223 2 181 190 10.1016/j.canlet.2004.09.041 15896452
24. Curcumin: the story so far. RA Sharma AJ Gescher WP Steward, Eur J Cancer 2005 41 13 1955 1968 10.1016/j.ejca.2005.05.009 16081279
25. Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters. MA Valasek JJ Repa G Quan JM Dietschy SD Turley, Am J Physiol Gastrointest Liver Physiol 2008 295 4 813 822 10.1152/ajpgi.90372.2008 18718997
26. Sitosterol reduces messenger RNA and protein expression levels of Niemann-Pick C1-like 1 in FHs 74 Int cells. ED Jesch JM Seo TP Carr JY Lee, Nutr Res 2009 29 12 859 866 10.1016/j.nutres.2009.10.016 19963159
27. Polyunsaturated fatty acids down-regulate in vitro expression of the key intestinal cholesterol absorption protein NPC1L1: no effect of monounsaturated nor saturated fatty acids. A Alvaro R Rosales L Masana JC Vallve, J Nutr Biochem 2009 19443194
28. The probiotic Lactobacillus acidophilus reduces cholesterol absorption through the down-regulation of Niemann-Pick C1-like 1 in Caco-2 cells. Y Huang Y Zheng, Br J Nutr 2009 1 6
29. HNF4alpha is a crucial modulator of the cholesterol-dependent regulation of NPC1L1. Y Iwayanagi T Takada H Suzuki, Pharm Res 2008 25 5 1134 1141 10.1007/s11095-007-9496-9 18080173
30. Modulation of transcription factors by curcumin. S Shishodia T Singh MM Chaturvedi, Adv Exp Med Biol 2007 595 127 148 17569208